Form 8-K - Current report:
SEC Accession No. 0001193125-25-064685
Filing Date
2025-03-27
Accepted
2025-03-27 07:15:19
Documents
24
Period of Report
2025-03-27
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d823727d8k.htm   iXBRL 8-K 31148
2 EX-99.1 d823727dex991.htm EX-99.1 12819
6 GRAPHIC g823727ex99_1s10g1.jpg GRAPHIC 38996
7 GRAPHIC g823727ex99_1s1g1.jpg GRAPHIC 120374
8 GRAPHIC g823727ex99_1s2g1.jpg GRAPHIC 179431
9 GRAPHIC g823727ex99_1s3g1.jpg GRAPHIC 65333
10 GRAPHIC g823727ex99_1s4g1.jpg GRAPHIC 95821
11 GRAPHIC g823727ex99_1s5g1.jpg GRAPHIC 82693
12 GRAPHIC g823727ex99_1s6g1.jpg GRAPHIC 80626
13 GRAPHIC g823727ex99_1s7g1.jpg GRAPHIC 94028
14 GRAPHIC g823727ex99_1s8g1.jpg GRAPHIC 100327
15 GRAPHIC g823727ex99_1s9g1.jpg GRAPHIC 107006
  Complete submission text file 0001193125-25-064685.txt   1502075

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rgls-20250327.xsd EX-101.SCH 2857
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgls-20250327_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgls-20250327_pre.xml EX-101.PRE 11266
26 EXTRACTED XBRL INSTANCE DOCUMENT d823727d8k_htm.xml XML 3645
Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

EIN.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35670 | Film No.: 25775257
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)